Skip to main content

Table 2 The relationship of clinicopathological variables and immunohistochemical features with overall survival (OS) in laryngeal squamous cell carcinoma patients

From: Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study

Feature

No. of patients

Overall survival (%)

χ 2

P a

  

3 y

5 y

10 y

  

Gender

   

1.539

0.215

Female

3(2.0%)

100

100

100

  

Male

145(98.0%)

77.2

71.0

55.6

  

Age (years)b

   

0.019

0.889

< 60

72(48.6%)

80.6

72.2

54.9

  

≥60

76(51.4%)

75

71.1

57.6

  

Histological grade

   

2.976

0.226

Well

70(47.3%)

85.7

81.4

60.8

  

Moderately

58(39.2%)

69.0

62.1

51.2

  

Poorly

20(13.5%)

75.0

65.0

55.0

  

Smoking indexc

   

3.745

0.053

< 600

67(45.3%)

83.6

77.6

66.2

  

≥600

81(54.7%)

72.8

66.7

48.4

  

Alcohol consumption

   

0.033

0.856

No

88(59.5%)

79.5

71.6

56.8

  

Yes

60(40.5%)

75.0

71.7

55.6

  

Primary Site

   

8.974

0.011*

Glottic

104(70.3%)

82.7

77.9

63.1

  

Supraglottic

39(26.3%)

64.1

53.8

39.0

  

Subglottic

5(3.4%)

80.0

80.0

40.0

  

T Stage

   

6.201

0.013*

1-2

101(68.2%)

81.2

78.2

62.6

  

3-4

47(31.8%)

70.2

57.4

43.5

  

Cervical lymph node metastasis

   

21.263

< 0.001**

Negative

129(87.2%)

82.9

77.5

61.7

  

Positive

19(12.8%)

42.1

31.6

21.1

  

TNM Stage

   

7.736

0.005**

I-II

96(64.9%)

82.3

79.6

63.8

  

III-IV

52(35.1%)

69.2

57.7

43.3

  

Total radiation dose

   

1.671

0.196

< 60 Gy

61(41.2%)

78.7

75.4

62.9

  

≥60 Gy

87(58.8%)

77.0

69.0

51.7

  

Margin

   

0.395

0.530

Negative

68(45.9%)

82.4

76.5

57.9

  

Positive

80(54.1%)

73.8

67.5

55.0

  

TGM2

   

6.308

0.012*

High

70(47.3%)

72.9

64.3

45.5

  

Low

78(52.7%)

82.1

78.2

65.7

  

BNIP3

   

8.586

0.003**

High

106(71.6%)

79.2

75.5

64.4

  

Low

42(28.4%)

71.4

61.9

35.7

  

TGM2 & BNIP3

   

19.021

< 0.001**

TGM2 (-) & BNIP3 (+)

49(33.1%)

87.8

85.7

76.9

  

TGM2 (+) & BNIP3 (-)

13(8.8%)

69.2

53.8

15.4

  

TGM2 (+) & BNIP3 (+)

57(38.5%)

73.7

66.7

53.8

  

TGM2 (-) & BNIP3 (-)

29(19.6%)

72.4

65.5

46.3

  
  1. a Log-rank test. b Patients were divided into two groups according to the median age. c Smoking index is defined as the number of cigarettes used per day × the total smoking time (years). *P < 0.05, **P < 0.01